Katy M. Webb - Publications
Affiliations: |
Year | Citation | Score | |||
---|---|---|---|---|---|
2014 | Moran LM, Fitting S, Booze RM, Webb KM, Mactutus CF. Neonatal intrahippocampal HIV-1 protein Tat(1-86) injection: neurobehavioral alterations in the absence of increased inflammatory cytokine activation. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 38: 195-203. PMID 25285887 DOI: 10.1016/j.ijdevneu.2014.09.004 | 0.92 | |||
2013 | Moran LM, Booze RM, Webb KM, Mactutus CF. Neurobehavioral alterations in HIV-1 transgenic rats: evidence for dopaminergic dysfunction. Experimental Neurology. 239: 139-47. PMID 23063600 DOI: 10.1016/j.expneurol.2012.10.008 | 0.92 | |||
2012 | Moran LM, Aksenov MY, Booze RM, Webb KM, Mactutus CF. Adolescent HIV-1 transgenic rats: evidence for dopaminergic alterations in behavior and neurochemistry revealed by methamphetamine challenge. Current Hiv Research. 10: 415-24. PMID 22591365 DOI: 10.2174/157016212802138788 | 0.92 | |||
2011 | Hadlock GC, Webb KM, McFadden LM, Chu PW, Ellis JD, Allen SC, Andrenyak DM, Vieira-Brock PL, German CL, Conrad KM, Hoonakker AJ, Gibb JW, Wilkins DG, Hanson GR, Fleckenstein AE. 4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse. The Journal of Pharmacology and Experimental Therapeutics. 339: 530-6. PMID 21810934 DOI: 10.1124/jpet.111.184119 | 0.92 | |||
2010 | Webb KM, Aksenov MY, Mactutus CF, Booze RM. Evidence for developmental dopaminergic alterations in the human immunodeficiency virus-1 transgenic rat. Journal of Neurovirology. 16: 168-73. PMID 20337512 DOI: 10.3109/13550281003690177 | 0.92 | |||
2009 | Webb KM, Mactutus CF, Booze RM. The ART of HIV therapies: dopaminergic deficits and future treatments for HIV pediatric encephalopathy. Expert Review of Anti-Infective Therapy. 7: 193-203. PMID 19254168 DOI: 10.1586/14787210.7.2.193 | 0.92 | |||
Show low-probability matches. |